Strongbridge Biopharma adds Jeffrey Sherman to board of directors
Dr. Sherman has more than 25 years of research, clinical development, regulatory and commercialization experience within the biopharmaceutical industry.
Since 2009, he has served as chief medical officer and an executive vice president at Horizon Pharma.
He also previously held senior leadership positions at IDM Pharma, Takeda Global Research and Development, NeoPharm, Searle/Pharmacia, Bristol-Myers Squibb, and is a past president of the Drug Information Association (DIA).
Dr. Sherman earned his M.D. from the Rosalind Franklin University of Medicine and Science/The Chicago Medical School.
He completed internship and residency programs at Northwestern University Feinberg School of Medicine, where he currently serves as an adjunct assistant professor, and a fellowship position at the University of California San Francisco.
He received a B.A. in Biology from Lake Forest College. ■
LATEST MOVES FROM Ireland
- Roy Dunbar elected to board of Johnson Controls
- C&C Group appoints Andrea Pozzi to board
- Bank of Ireland appoints Francesca McDonagh as CEO
- Paddy Power appoints Emer Timmons as director
- Prothena appoints Sarah Noonberg as CMO
More inside POST